[ad_1]
Biontech and Pfizer vaccine
“Like a bad hangover”: test subjects report how they felt after corona vaccination
Mainz-based pharmaceutical company BioNTech sees the federal government’s goal of vaccinating 70% of Germany’s citizens against Covid-19 by the summer as realistic. “We will do everything possible to make it work. If all the factories work, it should be possible to achieve the goal,” the company’s chief financial officer, Sierk Poetting, told the “Stuttgarter Nachrichten” and “Stuttgarter Zeitung” newspapers. Regarding approval of the vaccine in the EU, Poetting said a date in 2020 was within the theoretically possible range. BioNTech, which is about to be approved worldwide with its corona vaccine, could “at least deliver up to 50 million doses of vaccine this year.” The Mainz biotech company wants to sell its corona vaccine below the usual market prices. However, the price of the vaccine will reflect the financial risks assumed by its private investors, BioNTech chief strategy officer Ryan Richardson said Tuesday at a “Financial Times” online event. There will likely be different prices in different countries, Richardson added, without elaborating. BioNTech and its US partner Pfizer on Monday announced a crucial study success with their corona vaccine. Consequently, the vaccine offered more than 90 percent protection against Covid-19.
Biontech and Pfizer want to request US approval for their vaccine this month, and Europe will follow soon. A study showed the first promising results. Several test subjects report their vaccination.
Biontech and Pfizer announced that their vaccine was more than 90 percent effective in an initial study. Tens of thousands of subjects have been vaccinated against it worldwide. Some of them tell their experiences to the media.
The Youtube channel “Breaking Lab” spoke with one of the German test candidates. He claims to be a doctor and does not appear in the video. Reports on the course of the study. Consequently, he was one of 800 German test subjects and was first thoroughly examined by a doctor. Blood was drawn from it and a crown smear was taken. He then received two injections in his upper arm three weeks apart.
He was “pretty sure” that it was part of the half who actually got the vaccine and not a dose of placebo. Eventually, she developed reactions to the vaccine: swelling in her upper arm, a slight tingling sensation, and a slight rise in temperature the next day. About a week after the second dose, you will probably receive the vaccine, advises the doctor, whose age is not an issue.
Corona vaccine: the doctor also participated in the study because of the patients
He also signed up for the study to protect his patients. “I have 100 dialysis patients, 75 kidney transplants and 50 who have water running into their lungs all the time. They would all be at massive risk of a corona infection. This risk is now reduced to the maximum for me,” the man said during The phone call. Canal operator Jacob Beautemps.
The British “Daily Mail” also spoke with test subjects from the US vaccine study Glenn Geshields, 44, reports a “severe hangover” he had after the first vaccination. When he got home, he felt bad and slept a little. Then he woke up hungry and “probably ate more in 24 hours than ever.” He also had a headache. With the second vaccination, the “hangover was much milder,” Geshields reports. Not only from the reaction, he is also sure that it will be one of those who received the vaccine. The Texan had “cheated,” as he calls it, and he had an antibody test after his injections, which came back positive.
Pfizer and Biontech want to produce more than 1 billion cans
The German doctor, who spoke to “Breaking Lab”, reported on other processes. You will be tested again after the second dose, that is, after three, six, twelve and 24 months. He was clearly in favor of a vaccine. “The dates are still early, but I can only recommend it,” says the doctor. “If you can get 90 percent protection with it, it would be so much better than, say, flu vaccination.”
After promising initial results with the crown vaccine from Biontech and Pfizer, expectations are growing around the world that an approved agent could soon make life a little more normal again. In the US, companies want to apply for an emergency license this month, Europe should follow soon. According to Pfizer and Biontech, vaccination protection should be established after two injections. They want to provide 50 million doses of vaccines this year and 1.3 billion next year worldwide.
Sources:Youtube, Breaking Lab / “Daily Mail”
